Kymera extends growth with $2.1B Sanofi deal
July 09, 2020 at 07:00 AM EDT
French drug giant Sanofi has evolved from one of Kymera Therapeutics Inc.’s investors to a development partner.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.